{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:13:33Z","timestamp":1788783213179,"version":"build-2803163510"},"reference-count":39,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,3,29]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A smaller relative volume of the peripheral pulmonary vasculature in asthma, termed \u201cvascular pruning\u201d, has been linked to greater disease severity, exacerbations, and airflow obstruction. It is not known whether this is reversible. Therefore, the study objective was to determine whether \u201closs\u201d of computed tomography (CT) measures of peripheral pulmonary vasculature is a modifiable feature of asthma pathophysiology by assessing its response to dupilumab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      27 adults with moderate-to-severe asthma received dupilumab (n=19) or placebo (n=8) every 2\u2005weeks for 16\u2005weeks. Chest CT scans acquired at baseline and follow-up were analysed to quantify pulmonary blood vessel volumes categorised by cross-sectional area (\u22645\u2005mm\n                      <jats:sup>2<\/jats:sup>\n                      as BV5 and \u226510\u2005mm\n                      <jats:sup>2<\/jats:sup>\n                      as BV10). These volumes were reported relative to the total blood volume (TBV) as BV5% and BV10%. Change in blood vessel volumes from baseline to follow-up were evaluated and correlated with changes in patient-reported outcomes, type-2 inflammatory biomarkers and measurements of airway structure and function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Following dupilumab treatment (but not placebo), BV5% increased by 1.0% (95% CI \u22120.2% to 4.5%, p=0.02) and BV10% decreased by 1.0% (95% CI \u22123.6% to 0.7%, p=0.03). The between-group difference in median change was 3.0% for BV5% (95% CI 0.6% to 5.5%; p=0.008) and \u22123.0% for BV10% (95% CI \u22125.2% to\u2009\u22121.0%; p=0.007). In dupilumab-treated participants, the increase in BV5% and decrease in BV10% was associated with improved Asthma Control Questionnaire-5, forced expiratory volume in 1\u2005s, fraction of exhaled nitric oxide and sputum eosinophil percentage (all p&lt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A redistribution of pulmonary blood volume toward smaller vessels was observed following dupilumab, suggesting that CT-derived pulmonary vascular measurements may be modifiable in asthma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.01850-2025","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:00:24Z","timestamp":1776358824000},"page":"01850-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Computed tomography-derived pulmonary blood volume distribution may be modifiable in asthma"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0902-132X","authenticated-orcid":false,"given":"Anusha A.","family":"Mappanasingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonni","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekamdeep","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandhitha","family":"Ragunayakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisarg","family":"Radadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Kjarsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2497-0258","authenticated-orcid":false,"given":"John E.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Venegas Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Hambly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-7211","authenticated-orcid":false,"given":"Manali","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Svenningsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026090704551079000_12.5.01850-2025.1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.1.9607066"},{"key":"2026090704551079000_12.5.01850-2025.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200602-189OC"},{"key":"2026090704551079000_12.5.01850-2025.3","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.12.902"},{"key":"2026090704551079000_12.5.01850-2025.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppul.21135","article-title":"The bronchial circulation\u2014worth a closer look: A review of the relationship between the bronchial vasculature and airway inflammation","volume":"45","author":"McCullagh","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"2026090704551079000_12.5.01850-2025.5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.1.9712141"},{"key":"2026090704551079000_12.5.01850-2025.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00048605"},{"key":"2026090704551079000_12.5.01850-2025.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2009.07.022"},{"key":"2026090704551079000_12.5.01850-2025.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200908-1189OC"},{"key":"2026090704551079000_12.5.01850-2025.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201301-0162OC"},{"key":"2026090704551079000_12.5.01850-2025.10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1164\/rccm.201712-2426OC","article-title":"Pruning of the pulmonary vasculature in asthma. The severe asthma research program (SARP) Cohort","volume":"198","author":"Ash","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026090704551079000_12.5.01850-2025.11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.202305-0849LE","article-title":"Pulmonary vascular differences in eosinophilic asthma after 2.5-years anti-IL-5R\u03b1 treatment","volume":"208","author":"McIntosh","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026090704551079000_12.5.01850-2025.12","doi-asserted-by":"publisher","DOI":"10.1159\/000199721"},{"key":"2026090704551079000_12.5.01850-2025.13","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2007-0441OC"},{"key":"2026090704551079000_12.5.01850-2025.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804092"},{"key":"2026090704551079000_12.5.01850-2025.15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.anai.2022.10.018","article-title":"Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction","volume":"130","author":"Hanania","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026090704551079000_12.5.01850-2025.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1102LE"},{"key":"2026090704551079000_12.5.01850-2025.17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2213-2600(24)00362-X","article-title":"Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial","volume":"13","author":"Castro","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026090704551079000_12.5.01850-2025.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1634OC"},{"key":"2026090704551079000_12.5.01850-2025.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.05.009"},{"key":"2026090704551079000_12.5.01850-2025.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1208PP"},{"key":"2026090704551079000_12.5.01850-2025.21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"2026090704551079000_12.5.01850-2025.22","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.2.8756799"},{"key":"2026090704551079000_12.5.01850-2025.23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200406-710ST"},{"key":"2026090704551079000_12.5.01850-2025.24","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14d29.x"},{"key":"2026090704551079000_12.5.01850-2025.25","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.2.76"},{"key":"2026090704551079000_12.5.01850-2025.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2020.04.025"},{"key":"2026090704551079000_12.5.01850-2025.27","doi-asserted-by":"crossref","unstructured":"Est\u00e9par RSJ , Ross JC , Krissian K , et al. Computational vascular morphometry for the assessment of pulmonary vascular disease based on scale-space particles. Proc IEEE Int Symp Biomed Imaging 2012: 1479\u20131482. doi:10.1109\/ISBI.2012.6235851","DOI":"10.1109\/ISBI.2012.6235851"},{"key":"2026090704551079000_12.5.01850-2025.28","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205160"},{"key":"2026090704551079000_12.5.01850-2025.29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI95693"},{"key":"2026090704551079000_12.5.01850-2025.30","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2971"},{"key":"2026090704551079000_12.5.01850-2025.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.3.805"},{"key":"2026090704551079000_12.5.01850-2025.32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chest.2023.12.015","article-title":"Use of quantitative CT imaging to identify bronchial thermoplasty responders","volume":"165","author":"Samant","year":"2024","journal-title":"Chest"},{"key":"2026090704551079000_12.5.01850-2025.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2025.05.013"},{"key":"2026090704551079000_12.5.01850-2025.34","doi-asserted-by":"crossref","first-page":"e12436","DOI":"10.1002\/pul2.12436","article-title":"Sex-related differences in pulmonary vascular volume distribution","volume":"14","author":"Wright","year":"2024","journal-title":"Pulm Circ"},{"key":"2026090704551079000_12.5.01850-2025.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30307-5"},{"key":"2026090704551079000_12.5.01850-2025.36","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1183\/23120541.00204-2019","article-title":"Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma","volume":"6","author":"Castro","year":"2020","journal-title":"ERJ Open Res"},{"key":"2026090704551079000_12.5.01850-2025.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.156091"},{"key":"2026090704551079000_12.5.01850-2025.38","doi-asserted-by":"crossref","first-page":"1168635","DOI":"10.3389\/fimmu.2023.1168635","article-title":"The transcriptional control of the VEGFA-VEGFR1 (FLT1) axis in alternatively polarized murine and human macrophages","volume":"14","author":"Domokos","year":"2023","journal-title":"Front Immunol"},{"key":"2026090704551079000_12.5.01850-2025.39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.5.2035"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01850-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:55:23Z","timestamp":1788782123000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01850-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,7]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1183\/23120541.01850-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01850-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}